Article Details
Retrieved on: 2023-12-22 20:18:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here